Balyasny Asset Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Hold |
86,005
| – | – | ﹤0.01% | 1891 |
|
|
2025
Q1 | $92.9K | Sell |
86,005
-648,999
| -88% | -$701K | ﹤0.01% | 1914 |
|
|
2024
Q4 | $1.29M | Sell |
735,004
-256,700
| -26% | -$449K | ﹤0.01% | 1218 |
|
|
2024
Q3 | $1.91M | Sell |
991,704
-6,458
| -0.6% | -$12.5K | ﹤0.01% | 1140 |
|
|
2024
Q2 | $1.77M | Sell |
998,162
-3,846,889
| -79% | -$6.81M | ﹤0.01% | 1088 |
|
|
2024
Q1 | $13.1M | Buy |
4,845,051
+2,662,864
| +122% | +$7.22M | 0.02% | 606 |
|
|
2023
Q4 | $4.82M | Sell |
2,182,187
-514,523
| -19% | -$1.14M | 0.01% | 789 |
|
|
2023
Q3 | $7.82M | Buy |
2,696,710
+595,020
| +28% | +$1.73M | 0.02% | 674 |
|
|
2023
Q2 | $4.06M | Buy |
+2,101,690
| New | +$4.06M | 0.01% | 831 |
|
|
2022
Q3 | – | Sell |
-1,137,361
| Closed | -$1.82M | – | 2566 |
|
|
2022
Q2 | $1.82M | Buy |
+1,137,361
| New | +$1.82M | 0.01% | 1174 |
|
|
2022
Q1 | – | Sell |
-700,000
| Closed | -$2.74M | – | 2316 |
|
|
2021
Q4 | $2.74M | Buy |
700,000
+381,009
| +119% | +$1.49M | 0.01% | 917 |
|
|
2021
Q3 | $2.1M | Buy |
+318,991
| New | +$2.1M | 0.01% | 917 |
|
|
2018
Q2 | – | Sell |
-25,488
| Closed | -$149K | – | 1774 |
|
|
2018
Q1 | $149K | Buy |
25,488
+14,388
| +130% | +$84.1K | ﹤0.01% | 1608 |
|
|
2017
Q4 | $65K | Buy |
+11,100
| New | +$65K | ﹤0.01% | 1754 |
|